Loading...

Lynda Diane Roman, MD

TitleAssociate Professor of Obstetrics & Gynecology
InstitutionUniversity of Southern California
DepartmentObstetrics & Gynecology
AddressIRD 520 2020 Zonal Ave
Off Campus
Los Angeles CA 90033
Phone+1 323 409 3405
vCardDownload vCard
    Other Positions
    TitleDivision Chief, Gynecologic Oncology

    TitleDirector, Gynecology Oncology Fellowship


    Collapse Overview 
    Collapse Overview
    Dr. Roman completed her fellowship in gynecologic oncology at the MD Anderson Cancer Center in Houston, Texas in 1991. Presently, she serves as Director of the Division of Gynecologic Oncology at the University of Southern California, as well as the Director of Research and the Fellowship Program Director. Also, Dr. Roman is the co-director of the Lynne Cohen Preventive Cancer Care Clinic at the USC/Norris Cancer Center. she has recently been appointed to the governing council of the Society of Gynecologic Oncologists.


    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Matsuo K, Blake EA, Machida H, Mandelbaum RS, Roman L, Wright JD. Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis. Gynecol Oncol. 2018 Jul 24. PMID: 30054103.
      View in: PubMed
    2. Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Enomoto T, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman L. Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma. Ann Surg Oncol. 2018 Jul 03. PMID: 29971677.
      View in: PubMed
    3. Matsuo K, Spragg SE, Ciccone MA, Blake EA, Ricker C, Pham HQ, Roman L. Nivolumab use for BRCA gene mutation carriers with recurrent epithelial ovarian cancer: A case series. Gynecol Oncol Rep. 2018 Aug; 25:98-101. PMID: 29998185.
      View in: PubMed
    4. Matsuo K, Machida H, Blake EA, Holman LL, Rimel BJ, Roman L, Wright JD. Trends and outcomes of women with synchronous endometrial and ovarian cancer. Oncotarget. 2018 Jun 19; 9(47):28757-28771. PMID: 29983894.
      View in: PubMed
    5. Matsuo K, Machida H, Mariani A, Mandelbaum RS, Glaser GE, Gostout BS, Roman L, Wright JD. Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer. J Gynecol Oncol. 2018 May 04. PMID: 30022633.
      View in: PubMed
    6. Matsuo K, Yabuno A, Hom MS, Shida M, Kakuda M, Adachi S, Mandelbaum RS, Ueda Y, Hasegawa K, Enomoto T, Mikami M, Roman L. Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer. Gynecol Oncol. 2018 Mar 12. PMID: 29605499.
      View in: PubMed
    7. Matei D, Ghamande S, Roman L, Alvarez Secord A, Nemunaitis J, Markham MJ, Nephew KP, Jueliger S, Oganesian A, Naim S, Su XY, Keer H, Azab M, Fleming GF. A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses. Clin Cancer Res. 2018 May 15; 24(10):2285-2293. PMID: 29500276.
      View in: PubMed
    8. Matsuo K, Tanabe K, Ikeda M, Shibata T, Kajiwara H, Miyazawa M, Miyazawa M, Hayashi M, Shida M, Hirasawa T, Roman L, Mikami M. Fully sialylated alpha-chain of complement 4-binding protein (A2160): a novel prognostic marker for epithelial ovarian carcinoma. Arch Gynecol Obstet. 2018 Mar; 297(3):749-756. PMID: 29340789.
      View in: PubMed
    9. Matsuo K, Ross MS, Machida H, Blake EA, Roman L. Trends of uterine carcinosarcoma in the United States. J Gynecol Oncol. 2018 Mar; 29(2):e22. PMID: 29400015.
      View in: PubMed
    10. Machida H, Blake EA, Eckhardt SE, Takiuchi T, Grubbs BH, Mikami M, Roman L, Matsuo K. Trends in single women with malignancy of the uterine cervix in United States. J Gynecol Oncol. 2018 Mar; 29(2):e24. PMID: 29400017.
      View in: PubMed
    11. Matsuo K, Ross MS, Im DD, Klobocista MM, Bush SH, Johnson MS, Takano T, Blake EA, Ikeda Y, Nishimura M, Ueda Y, Shida M, Hasegawa K, Baba T, Adachi S, Yokoyama T, Satoh S, Machida H, Yanai S, Iwasaki K, Miyake TM, Takeuchi S, Takekuma M, Nagano T, Yunokawa M, Pejovic T, Omatsu K, Shahzad MMK, Kelley JL, Ueland FR, Roman L. Significance of venous thromboembolism in women with uterine carcinosarcoma. Gynecol Oncol. 2018 Feb; 148(2):267-274. PMID: 29248197.
      View in: PubMed
    12. Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura M, Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MMK, Ueland FR, Kelley JL, Roman L. Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcoma. Gynecol Oncol. 2017 12; 147(3):565-571. PMID: 29056442.
      View in: PubMed
    13. Matsuo K, Roman L, Wright JD. Reply. Am J Obstet Gynecol. 2018 Feb; 218(2):264. PMID: 29061361.
      View in: PubMed
    14. Matsuo K, Johnson MS, Im DD, Ross MS, Bush SH, Yunokawa M, Blake EA, Takano T, Klobocista MM, Hasegawa K, Ueda Y, Shida M, Baba T, Satoh S, Yokoyama T, Machida H, Ikeda Y, Adachi S, Miyake TM, Iwasaki K, Yanai S, Takeuchi S, Nishimura M, Nagano T, Takekuma M, Shahzad MMK, Pejovic T, Omatsu K, Kelley JL, Ueland FR, Roman L. Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery. J Surg Oncol. 2017 Oct 16. PMID: 29044542.
      View in: PubMed
    15. Matsuo K, Machida H, Frimer M, Marcus JZ, Pejovic T, Roman L, Wright JD. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer. Gynecol Oncol. 2017 12; 147(3):558-564. PMID: 28986093.
      View in: PubMed
    16. Machida H, Eckhardt SE, Castaneda AV, Blake EA, Pham HQ, Roman L, Matsuo K. Single Marital Status and Infectious Mortality in Women With Cervical Cancer in the United States. Int J Gynecol Cancer. 2017 10; 27(8):1737-1746. PMID: 28704326.
      View in: PubMed
    17. Matsuo K, Purushotham S, Moeini A, Li G, Machida H, Liu Y, Roman L. A pilot study in using deep learning to predict limited life expectancy in women with recurrent cervical cancer. Am J Obstet Gynecol. 2017 12; 217(6):703-705. PMID: 28843741.
      View in: PubMed
    18. Matsuo K, Wong KK, Fotopoulou C, Blake EA, Robertson SE, Pejovic T, Frimer M, Pardeshi V, Hu W, Choi JS, Sun CC, Richmond AM, Marcus JZ, Hilliard MAM, Mostofizadeh S, Mhawech-Fauceglia P, Abdulfatah E, Post MD, Saglam O, Shahzad MMK, Karabakhtsian RG, Ali-Fehmi R, Gabra H, Roman L, Sood AK, Gershenson DM. Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma. J Surg Oncol. 2018 Feb; 117(2):236-244. PMID: 28787528.
      View in: PubMed
    19. Matsuo K, Machida H, Stone RL, Soliman PT, Thaker PH, Roman L, Wright JD. Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer. Obstet Gynecol. 2017 Aug; 130(2):403-410. PMID: 28697110.
      View in: PubMed
    20. Machida H, Moeini A, Ciccone MA, Mostofizadeh S, Takiuchi T, Brunette LL, Roman L, Matsuo K. Efficacy of Modified Dose-dense Paclitaxel in Recurrent Cervical Cancer. Am J Clin Oncol. 2017 Jul 31. PMID: 28763329.
      View in: PubMed
    21. Matsuo K, Machida H, Horowitz MP, Shahzad MMK, Guntupalli SR, Roman L, Wright JD. Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer. Am J Obstet Gynecol. 2017 11; 217(5):580.e1-580.e10. PMID: 28666700.
      View in: PubMed
    22. Matsuo K, Machida H, Ragab OM, Garcia-Sayre J, Yessaian AA, Roman L. Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer. J Surg Oncol. 2017 Sep; 116(4):482-491. PMID: 28543055.
      View in: PubMed
    23. Machida H, Maeda M, Cahoon SS, Scannell CA, Garcia-Sayre J, Roman L, Matsuo K. Endometrial cancer arising in adenomyosis versus endometrial cancer coexisting with adenomyosis: are these two different entities? Arch Gynecol Obstet. 2017 Jun; 295(6):1459-1468. PMID: 28444512.
      View in: PubMed
    24. Matsuo K, Machida H, Takiuchi T, Garcia-Sayre J, Yessaian AA, Roman L. Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy. Gynecol Oncol. 2017 Apr; 145(1):41-49. PMID: 28215841.
      View in: PubMed
    25. Matsuo K, Omatsu K, Ross MS, Johnson MS, Yunokawa M, Klobocista MM, Im DD, Bush SH, Ueda Y, Takano T, Blake EA, Hasegawa K, Baba T, Shida M, Satoh S, Yokoyama T, Machida H, Adachi S, Ikeda Y, Iwasaki K, Miyake TM, Yanai S, Nishimura M, Nagano T, Takekuma M, Takeuchi S, Pejovic T, Shahzad MM, Ueland FR, Kelley JL, Roman L. Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma. Gynecol Oncol. 2017 04; 145(1):78-87. PMID: 28215838.
      View in: PubMed
    26. Matsuo K, Machida H, Takiuchi T, Grubbs BH, Roman L, Sood AK, Gershenson DM. Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors. Gynecol Oncol. 2017 03; 144(3):496-502. PMID: 28131526.
      View in: PubMed
    27. Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman L, Wright JD. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer. Obstet Gynecol. 2017 01; 129(1):139-151. PMID: 27926642.
      View in: PubMed
    28. Matsuo K, Machida H, Ragab OM, Takiuchi T, Pham HQ, Roman L. Extent of pelvic lymphadenectomy and use of adjuvant vaginal brachytherapy for early-stage endometrial cancer. Gynecol Oncol. 2017 03; 144(3):515-523. PMID: 28017306.
      View in: PubMed
    29. Matsuo K, Ross MS, Bush SH, Yunokawa M, Blake EA, Takano T, Ueda Y, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Takeuchi S, Nishimura M, Iwasaki K, Yanai S, Klobocista MM, Johnson MS, Machida H, Hasegawa K, Miyake TM, Nagano T, Pejovic T, Shahzad MM, Im DD, Omatsu K, Ueland FR, Kelley JL, Roman L. Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma. Gynecol Oncol. 2017 Feb; 144(2):329-335. PMID: 27931750.
      View in: PubMed
    30. Tierney KE, Ji L, Dralla SS, Yoo E, Yessaian A, Pham HQ, Roman L, Sposto R, Mhawech-Fauceglia P, Lin YG. Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response. Gynecol Oncol. 2016 Dec; 143(3):650-654. PMID: 27771165.
      View in: PubMed
    31. Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman L, Wright JD. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Low-Grade Endometrial Cancer. Obstet Gynecol. 2016 10; 128(4):761-70. PMID: 27607873.
      View in: PubMed
    32. Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, Doherty JA, Schildkraut JM, Kjaer SK, Ness RB, Menon U, Berchuck A, Mukherjee B, Roman L, Pharoah PD, Chenevix-Trench G, Olson S, Hogdall E, Wu AH, Pike MC, Stram DO, Pearce CL. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. Int J Cancer. 2016 Dec 15; 139(12):2646-2654. PMID: 27420401.
      View in: PubMed
    33. Matsuo K, Cahoon SS, Yoshihara K, Shida M, Kakuda M, Adachi S, Moeini A, Machida H, Garcia-Sayre J, Ueda Y, Enomoto T, Mikami M, Roman L, Sood AK. Association of Low-Dose Aspirin and Survival of Women With Endometrial Cancer. Obstet Gynecol. 2016 Jul; 128(1):127-37. PMID: 27275802.
      View in: PubMed
    34. Matsuo K, Moeini A, Machida H, Fullerton ME, Shabalova A, Brunette LL, Roman L. Significance of venous thromboembolism in women with cervical cancer. Gynecol Oncol. 2016 09; 142(3):405-12. PMID: 27350404.
      View in: PubMed
    35. Matsuo K, Gualtieri MR, Cahoon SS, Toboni MD, Machida H, Moeini A, Hasegawa K, Shoupe D, Roman L. Contributing factors for menopausal symptoms after surgical staging for endometrial cancer. Menopause. 2016 05; 23(5):535-43. PMID: 26757269.
      View in: PubMed
    36. Lee AW, Ness RB, Roman L, Terry KL, Schildkraut JM, Chang-Claude J, Doherty JA, Menon U, Cramer DW, Gayther SA, Risch H, Gentry-Maharaj A, Goodman MT, Modugno F, Eilber U, Moysich KB, Berchuck A, Rossing MA, Jensen A, Wicklund KG, Cushing-Haugen KL, Hogdall E, Rudolph A, Thompson PJ, Wilkens LR, Kjaer SK, Carney ME, Stram DO, Ramus SJ, Wu AH, Pike MC, Pearce CL. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstet Gynecol. 2016 05; 127(5):828-36. PMID: 27054934; PMCID: PMC4892111 [Available on 05/01/17].
    37. Matsuo K, Jung CE, Hom MS, Gualtieri MR, Randazzo SC, Kanao H, Yessaian AA, Roman L. Predictive Factor of Conversion to Laparotomy in Minimally Invasive Surgical Staging for Endometrial Cancer. Int J Gynecol Cancer. 2016 Feb; 26(2):290-300. PMID: 26569058.
      View in: PubMed
    38. Matsuo K, Gualtieri MR, Cahoon SS, Jung CE, Paulson RJ, Shoupe D, Muderspach LI, Wakatsuki A, Wright JD, Roman L. Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer. Menopause. 2016 Feb; 23(2):189-96. PMID: 26173075.
      View in: PubMed
    39. Matsuo K, Moeini A, Machida H, Scannell CA, Casabar JK, Kakuda M, Adachi S, Garcia-Sayre J, Ueda Y, Roman L. Tumor Characteristics and Survival Outcome of Endometrial Cancer Arising in Adenomyosis: An Exploratory Analysis. Ann Surg Oncol. 2016 Mar; 23(3):959-67. PMID: 26542589.
      View in: PubMed
    40. Machida H, Casey JP, Garcia-Sayre J, Jung CE, Casabar JK, Moeini A, Kato K, Roman L, Matsuo K. Timing of Intrauterine Manipulator Insertion During Minimally Invasive Surgical Staging and Results of Pelvic Cytology in Endometrial Cancer. J Minim Invasive Gynecol. 2016 Feb 01; 23(2):234-41. PMID: 26475765.
      View in: PubMed
    41. Matsuo K, Garcia-Sayre J, Medeiros F, Casabar JK, Machida H, Moeini A, Roman L. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer. J Surg Oncol. 2015 Nov; 112(6):669-76. PMID: 26391212.
      View in: PubMed
    42. Da Silva DM, Woodham AW, Skeate JG, Rijkee LK, Taylor JR, Brand HE, Muderspach LI, Roman L, Yessaian AA, Pham HQ, Matsuo K, Lin YG, McKee GM, Salazar AM, Kast WM. Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C. Clin Immunol. 2015 Dec; 161(2):197-208. PMID: 26360252; PMCID: PMC4658296 [Available on 12/01/16].
    43. Matsuo K, Ramzan AA, Gualtieri MR, Mhawech-Fauceglia P, Machida H, Moeini A, Dancz CE, Ueda Y, Roman L. Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia. Gynecol Oncol. 2015 Nov; 139(2):261-7. PMID: 26238457.
      View in: PubMed
    44. Matsuo K, Hasegawa K, Yoshino K, Murakami R, Hisamatsu T, Stone RL, Previs RA, Hansen JM, Ikeda Y, Miyara A, Hiramatsu K, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Roman L, Gabra H, Fotopoulou C, Sood AK. Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma. Eur J Cancer. 2015 Sep; 51(14):1978-88. PMID: 26238017.
      View in: PubMed
    45. Machida H, Moeini A, Roman L, Matsuo K. Effects of imiquimod on vulvar Paget's disease: a systematic review of literature. Gynecol Oncol. 2015 Oct; 139(1):165-71. PMID: 26193428.
      View in: PubMed
    46. Lawrenson K, Pakzamir E, Liu B, Lee JM, Delgado MK, Duncan K, Gayther SA, Liu S, Roman L, Mhawech-Fauceglia P. Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium. PLoS One. 2015; 10(7):e0130909. PMID: 26132201; PMCID: PMC4488511.
    47. Matsuo K, Tierney KE, Schneider DM, Mhawech-Fauceglia P, Roman L, Gershenson DM. Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series. Gynecol Oncol Rep. 2015 Aug; 13:36-9. PMID: 26425718; PMCID: PMC4563586.
    48. Matsuo K, Opper NR, Roman L. In reply. Obstet Gynecol. 2015 Jun; 125(6):1498. PMID: 26000531.
      View in: PubMed
    49. Matsuo K, Hom MS, Moeini A, Machida H, Takeshima N, Roman L, Sood AK. Significance of monocyte counts on tumor characteristics and survival outcome of women with endometrial cancer. Gynecol Oncol. 2015 Aug; 138(2):332-8. PMID: 26013698.
      View in: PubMed
    50. Matsuo K, Opper NR, Ciccone MA, Garcia J, Tierney KE, Baba T, Muderspach LI, Roman L. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome. Obstet Gynecol. 2015 Feb; 125(2):424-33. PMID: 25569000.
      View in: PubMed
    51. Pearce CL, Stram DO, Ness RB, Stram DA, Roman L, Templeman C, Lee AW, Menon U, Fasching PA, McAlpine JN, Doherty JA, Modugno F, Schildkraut JM, Rossing MA, Huntsman DG, Wu AH, Berchuck A, Pike MC, Pharoah PDP. Population distribution of lifetime risk of ovarian cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2015 Apr; 24(4):671-676. PMID: 25623732; PMCID: PMC4892114.
    52. Wu E, Rogers A, Ji L, Sposto R, Church T, Roman L, Tripathy D, Lin YG. Escalation of oncologic services at the end of life among patients with gynecologic cancer at an urban, public hospital. J Oncol Pract. 2015 Mar; 11(2):e163-9. PMID: 25604595; PMCID: PMC4371122.
    53. Matsuo K, Yoshino K, Hasegawa K, Murakami R, Ikeda Y, Adachi S, Hiramatsu K, Yokoyama T, Nishimura M, Sheridan TB, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Fotopoulou C, Roman L, Sood AK. Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion. Gynecol Oncol. 2015 Feb; 136(2):198-204. PMID: 25497604.
      View in: PubMed
    54. Piatek CI, Raja GL, Ji L, Gitlitz BJ, Dorff TB, Quinn DI, Hu J, El-Khoueiry AB, Pham HQ, Roman L, Garcia AA. Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors. Cancer Chemother Pharmacol. 2014 Dec; 74(6):1227-34. PMID: 25374407.
      View in: PubMed
    55. Matsuo K, Cahoon SS, Gualtieri M, Scannell CA, Jung CE, Takano T, Paulson RJ, Muderspach LI, Roman L. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer. Ann Surg Oncol. 2014 Dec; 21(13):4246-55. PMID: 25001096.
      View in: PubMed
    56. Matsuo K, Yoshino K, Hiramatsu K, Banzai C, Hasegawa K, Yasuda M, Nishimura M, Sheridan TB, Ikeda Y, Shiki Y, Mabuchi S, Enomoto T, Kimura T, Fujiwara K, Roman L, Sood AK. Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancer. Obstet Gynecol. 2014 May; 123(5):957-65. PMID: 24785846; PMCID: PMC4174541.
    57. Matsuo K, Sheridan TB, Mabuchi S, Yoshino K, Hasegawa K, Studeman KD, Im DD, Rosenshein NB, Roman L, Sood AK. Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma. Gynecol Oncol. 2014 Jun; 133(3):473-9. PMID: 24674832; PMCID: PMC4170217.
    58. Lentz SE, Tierney KE, Weaver FA, Roman L. Abdominal aortic resection and Y-graft placement to achieve complete cytoreduction in stage IIIc ovarian carcinoma. Obstet Gynecol. 2014 Feb; 123(2 Pt 2 Suppl 2):486-8. PMID: 24413236.
      View in: PubMed
    59. Herzog TJ, Monk BJ, Rose PG, Braly P, Hines JF, Bell MC, Wenham RM, Secord AA, Roman L, Einstein MH, Drake RD, Childs BH. A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube. Gynecol Oncol. 2014 Mar; 132(3):517-25. PMID: 24476788.
      View in: PubMed
    60. Tierney KE, Lin PS, Amezcua C, Matsuo K, Ye W, Felix JC, Roman L. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease. Am J Obstet Gynecol. 2014 Apr; 210(4):366.e1-366.e5. PMID: 24370689.
      View in: PubMed
    61. Chandavarkar U, Kuperman JM, Muderspach LI, Opper N, Felix JC, Roman L. Endometrial echo complex thickness in postmenopausal endometrial cancer. Gynecol Oncol. 2013 Oct; 131(1):109-12. PMID: 23917081.
      View in: PubMed
    62. Cohn DE, Leitao M, Levenback C, Berkowitz R, Roman L, Lucci J, Kim S, Lancaster J, Odunsi K, Wakabayashi M, Goff BA. Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative. Gynecol Oncol. 2013 Sep; 130(3):403-6. PMID: 23718934.
      View in: PubMed
    63. Matsuo K, Yessaian AA, Lin YG, Pham HQ, Muderspach LI, Liebman HA, Morrow CP, Roman L. Predictive model of venous thromboembolism in endometrial cancer. Gynecol Oncol. 2013 Mar; 128(3):544-51. PMID: 23262205.
      View in: PubMed
    64. Matsuo K, Sheridan TB, Yoshino K, Miyake T, Hew KE, Im DD, Rosenshein NB, Mabuchi S, Enomoto T, Kimura T, Sood AK, Roman L. Significance of lymphovascular space invasion in epithelial ovarian cancer. Cancer Med. 2012 Oct; 1(2):156-64. PMID: 23342265; PMCID: PMC3544453.
    65. Matsuo K, Fleischman F, Ghattas CS, Gabrielyan AS, Ballard CA, Roman L, Morrow CP. Successful extraction of cardiac-extending intravenous leiomyomatosis through gonadal vein. Fertil Steril. 2012 Nov; 98(5):1341-5.e1. PMID: 22902061.
      View in: PubMed
    66. Garcia AA, Yessaian A, Pham H, Facio G, Muderspach L, Roman L. Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer. Cancer Invest. 2012 May; 30(4):295-9. PMID: 22468744.
      View in: PubMed
    67. Matsuo K, Prather CP, Ahn EH, Eno ML, Tierney KE, Yessaian AA, Im DD, Rosenshein NB, Roman L. Significance of perioperative infection in survival of patients with ovarian cancer. Int J Gynecol Cancer. 2012 Feb; 22(2):245-53. PMID: 22228425.
      View in: PubMed
    68. Matsuo K, Blake EA, Yessaian AA, Roman L. Long-term pegylated liposomal doxorubicin use and oromaxillary squamous cell carcinoma in endometrial cancer. Oncologist. 2012; 17(12):1598-9. PMID: 23263923; PMCID: PMC3528394.
    69. Campan M, Moffitt M, Houshdaran S, Shen H, Widschwendter M, Daxenbichler G, Long T, Marth C, Laird-Offringa IA, Press MF, Dubeau L, Siegmund KD, Wu AH, Groshen S, Chandavarkar U, Roman L, Berchuck A, Pearce CL, Laird PW. Genome-scale screen for DNA methylation-based detection markers for ovarian cancer. PLoS One. 2011; 6(12):e28141. PMID: 22163280; PMCID: PMC3233546.
    70. Reynolds EA, Tierney K, Keeney GL, Felix JC, Weaver AL, Roman L, Cliby WA. Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type. Obstet Gynecol. 2010 Nov; 116(5):1150-7. PMID: 20966701.
      View in: PubMed
    71. Matsuo K, Lin YG, Roman L, Sood AK. Overcoming platinum resistance in ovarian carcinoma. Expert Opin Investig Drugs. 2010 Nov; 19(11):1339-54. PMID: 20815774; PMCID: PMC2962713.
    72. Monk BJ, Sill MW, Burger RA, Gray HJ, Buekers TE, Roman L. Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol. 2009 Mar 01; 27(7):1069-74. PMID: 19139430; PMCID: PMC2667811.
    73. Schultheis AM, Lurje G, Rhodes KE, Zhang W, Yang D, Garcia AA, Morgan R, Gandara D, Scudder S, Oza A, Hirte H, Fleming G, Roman L, Lenz HJ. Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab. Clin Cancer Res. 2008 Nov 15; 14(22):7554-63. PMID: 19010874; PMCID: PMC2586993.
    74. Garcia AA, Hirte H, Fleming G, Yang D, Tsao-Wei DD, Roman L, Groshen S, Swenson S, Markland F, Gandara D, Scudder S, Morgan R, Chen H, Lenz HJ, Oza AM. Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia. J Clin Oncol. 2008 Jan 01; 26(1):76-82. PMID: 18165643.
      View in: PubMed
    75. Garcia AA, Blessing JA, Vaccarello L, Roman L. Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Am J Clin Oncol. 2007 Aug; 30(4):428-31. PMID: 17762444.
      View in: PubMed
    76. Brinkman JA, Hughes SH, Stone P, Caffrey AS, Muderspach LI, Roman L, Weber JS, Kast WM. Therapeutic vaccination for HPV induced cervical cancers. Dis Markers. 2007; 23(4):337-52. PMID: 17627067; PMCID: PMC3851105.
    77. Lowe MP, Bahador A, Muderspach LI, Burnett A, Santos L, Caffrey A, Roman L, Morrow CP. Feasibility of laparoscopic extraperitoneal surgical staging for locally advanced cervical carcinoma in a gynecologic oncology fellowship training program. J Minim Invasive Gynecol. 2006 Sep-Oct; 13(5):391-7. PMID: 16962520.
      View in: PubMed
    78. Gordon MS, Matei D, Aghajanian C, Matulonis UA, Brewer M, Fleming GF, Hainsworth JD, Garcia AA, Pegram MD, Schilder RJ, Cohn DE, Roman L, Derynck MK, Ng K, Lyons B, Allison DE, Eberhard DA, Pham TQ, Dere RC, Karlan BY. Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status. J Clin Oncol. 2006 Sep 10; 24(26):4324-32. PMID: 16896006.
      View in: PubMed
    79. Chernofsky MR, Felix JC, Muderspach LI, Morrow CP, Ye W, Groshen SG, Roman L. Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix. Gynecol Oncol. 2006 Feb; 100(2):288-93. PMID: 16182347.
      View in: PubMed
    80. Roman L. Pregnancy after radical vaginal trachelectomy: maybe not such a risky undertaking after all. Gynecol Oncol. 2005 Jul; 98(1):1-2. PMID: 15946730.
      View in: PubMed
    81. Mateo R, Singh G, Jabbour N, Palmer S, Genyk Y, Roman L. Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors. Gynecol Oncol. 2005 Apr; 97(1):266-70. PMID: 15790474.
      View in: PubMed
    82. Garcia AA, Roman L, Muderspach L, O'meara A, Facio G, Edwards S, Burnett A. Phase I clinical trial of topotecan and pegylated liposomal doxorubicin. Cancer Invest. 2005; 23(8):665-70. PMID: 16377584.
      View in: PubMed
    83. Burnett AF, O'Meara AT, Bahador A, Roman L, Morrow CP. Extraperitoneal laparoscopic lymph node staging: the University of Southern California experience. Gynecol Oncol. 2004 Oct; 95(1):189-92. PMID: 15385130.
      View in: PubMed
    84. Garcia AA, O'Meara A, Bahador A, Facio G, Jeffers S, Kim DY, Roman L. Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer. Gynecol Oncol. 2004 May; 93(2):493-8. PMID: 15099968.
      View in: PubMed
    85. Nouriani M, Bahador A, Berek JS, Cheng JP, Chi DS, Cliby WA, Del Priore G, Dodson MK, Duggan BD, Gershenson DM, Lentz SE, Penson RT, Robinson WR, Rodriguez M, Roman L, Yu MC, Zempolich K, Dubeau L. Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy. Clin Cancer Res. 2004 Apr 15; 10(8):2681-6. PMID: 15102671.
      View in: PubMed
    86. Burnett AF, Roman L, O'Meara AT, Morrow CP. Radical vaginal trachelectomy and pelvic lymphadenectomy for preservation of fertility in early cervical carcinoma. Gynecol Oncol. 2003 Mar; 88(3):419-23. PMID: 12648596.
      View in: PubMed